Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Medshine Discovery synthesizes new factor XIa inhibitors

Nov. 6, 2020

Adakveo approved in Europe to prevent VOCs in patients with sickle cell disease

Nov. 4, 2020

A novel inducer of fetal hemoglobin with improved PK and PD properties

Nov. 3, 2020

INSERM and collaborators describe hematopoietic stem cells including beta globin gene

Nov. 2, 2020

IND in effect for Fulcrum's phase I study of FTX-6058 for sickle cell disease

Oct. 5, 2020

Roche opens enrollment in phase III studies of crovalimab for PNH

Oct. 2, 2020

Discovery of new potent, selective and orally bioavailable inhibitors of factor XI

Oct. 2, 2020

BCX-9930 shows clinical benefit as monotherapy in treatment-naive patients with PNH

Oct. 1, 2020

Enaroy approved in Japan for anemia associated with chronic kidney disease

Sep. 29, 2020

FDA approves Nucala for hypereosinophilic syndrome

Sep. 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...